DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

About this update from Dariohealth Corp.

[{"type":"list","items":[{"val":[{"type":"text","content":"Fourth quarter 2025 revenues grew sequentially to $5.2 million as compared to $5.0 million in the third quarter of 2025","length":119,"tagName":"p"}]},{"val":[{"type":"text","content":"2025 full-year revenue was $22.4 million, compared to $27.0 million in 2024, due entirely to a scope change and nonrenewal from a single legacy client that came through the Twill, Inc. ("Twill") acquisition — unrelated to demand — partially offset by organic revenue growth ","length":298,"tagName":"p"}]},{"val":[{"type":"text","content":"The 2025 sales season — Dario's strongest on record — generated $12.9 million in contracted and late stage, annual recurring revenue ("ARR") set to contribute revenue in 2026 and 2027 and position the Company for a high-growth trajectory","length":256,"tagName":"p"}]},{"val":[{"type":"text","content":"GAAP gross margins increased to 57% in 2025 from 49% in 2024 and Non-GAAP gross margins have sustained at 80% for 2 years on the core B2B2C business ","length":148,"tagName":"p"}]},{"val":[{"type":"text","content":"Fourth quarter 2025 delivered the lowest operating expense run-rate on both a GAAP and Non-GAAP basis since Twill's acquisition, reducing Non-GAAP operating expenses by 28% year-over-year, from $12.4 million to $9.0 million, leading to continued improvements in operating loss for the fourth quarter and full year","length":317,"tagName":"p"}]},{"val":[{"type":"text","content":"Pipeline of commercial opportunities grew to $122 million as of December 31 2025, based on 200+ opportunities that are B2B2C ","length":124,"tagName":"p"}]},{"val":[{"type":"text","content":"Increased demand for Dario's musculoskeletal ("MSK") product in the B2C market, with 36% growth in the fourth quarter of 2025 and continued expansion expected in international markets","length":197,"tagName":"p"}]},{"val":[{"type":"text","content":"Dario will host an investor conference call and webcast at 8:30 a.m. ET today","length":87,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":1546,"olType":false},{"type":"text","content":"NEW YORK, March 19, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced i...

More updates from Dariohealth Corp.